Neuromyelitis Optica Spectrum Disorder (NMOSD) Market 2024-2028
Quick Buy buy_cart
Overview Scope Companies Subscription
overview_1
Incremental Growth2024-2028 (US$mn)

$ 205.1

overview_2
2024 Year-over-Year Growth

6.23%

overview_3
CAGR (2024-2028)

6.78%

overview_4
Report Coverage

Global

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Segmentation

Market Segmentation & Scope
Application
Hospitals Specialty clinics Homecare
Type
With aquaporin-4 antibodies Without aquaporin-4 antibodies

Geography

Europe

UK France Germany

APAC

China India Japan South Korea

North America

US Canada

South America

Brazil

Middle East and Africa

UAE

Market Segment by Geographic Landscape

regional_img

38%

of the growth will originate

from North America

Global Market Size 2018 - 2028 (US$ Mn)

Market is segmented by Application into Hospitals, Specialty clinics, Homecare

The Hospitals is expected to be largest growing segment during 2024-2028

Largest Segment - Hospitals

US$ 1,127.80 Mn

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market by Application into Hospitals; 2018-2028 (US$ Mn)

Hospitals Market Revenue and Forecast 2018-2028 (US$ Mn)

Hospitals

  • Hospitals Market Size and Forecast 2018 to 2028 (US$ Mn)

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market by Application into Specialty clinics; 2018-2028 (US$ Mn)

Specialty clinics Market Revenue and Forecast 2018-2028 (US$ Mn)

Specialty clinics

  • Specialty clinics Market Size and Forecast 2018 to 2028 (US$ Mn)

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market by Application into Homecare; 2018-2028 (US$ Mn)

Homecare Market Revenue and Forecast 2018-2028 (US$ Mn)

Homecare

  • Homecare Market Size and Forecast 2018 to 2028 (US$ Mn)

Market is segmented by Type into With aquaporin-4 antibodies, Without aquaporin-4 antibodies

The With aquaporin-4 antibodies is expected to be largest growing segment during 2024-2028

Largest Segment - With aquaporin-4 antibodies

US$ 1,312.30 Mn

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Segmentation, by Type (US$ Mn)

Type 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 CAGR (%)
With aquaporin-4 antibodies 243.00 XX XX XX XX XX XX XX XX XX XX XX
Without aquaporin-4 antibodies XX 189.20 XX XX XX XX XX XX XX XX XX XX

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market by Type into With aquaporin-4 antibodies; 2018-2028 (US$ Mn)

With aquaporin-4 antibodies Market Revenue and Forecast 2018-2028 (US$ Mn)

With aquaporin-4 antibodies

  • With aquaporin-4 antibodies Market Size and Forecast 2018 to 2028 (US$ Mn)

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market by Type into Without aquaporin-4 antibodies; 2018-2028 (US$ Mn)

Without aquaporin-4 antibodies Market Revenue and Forecast 2018-2028 (US$ Mn)

Without aquaporin-4 antibodies

  • Without aquaporin-4 antibodies Market Size and Forecast 2018 to 2028 (US$ Mn)

Market is segmented by Geography into North America, Europe, Asia, ROW

The North America is estimated to contribute 38% to the growth of global market during the forecast period 2024-2028.

Largest Segment - North America

38%

Regional share of different regions, including North America, Europe, Asia, Rest of World (ROW)

Region 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 CAGR (%)
North America 175.40 XX XX XX XX XX XX XX XX XX XX XX
Europe XX 126.50 XX XX XX XX XX XX XX XX XX XX
Asia XX XX 90.20 XX XX XX XX XX XX XX XX XX
ROW XX XX XX 45.70 47.80 XX XX XX XX XX XX XX

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Geography into North America; 2018-2028 (US$ Mn)

North America Market Revenue and Forecast 2018-2028 (US$ Mn)

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Country into Canada; 2018-2028 (US$ Mn)

Canada Market Revenue and Forecast 2018-2028 (US$ Mn)

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Country into US; 2018-2028 (US$ Mn)

US Market Revenue and Forecast 2018-2028 (US$ Mn)

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Geography into Europe; 2018-2028 (US$ Mn)

Europe Market Revenue and Forecast 2018-2028 (US$ Mn)

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Country into UK; 2018-2028 (US$ Mn)

UK Market Revenue and Forecast 2018-2028 (US$ Mn)

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Geography into Asia; 2018-2028 (US$ Mn)

Asia Market Revenue and Forecast 2018-2028 (US$ Mn)

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Country into China; 2018-2028 (US$ Mn)

China Market Revenue and Forecast 2018-2028 (US$ Mn)

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Country into India; 2018-2028 (US$ Mn)

India Market Revenue and Forecast 2018-2028 (US$ Mn)

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Geography into ROW; 2018-2028 (US$ Mn)

ROW Market Revenue and Forecast 2018-2028 (US$ Mn)

Major Companies

Market Companies

Name Profile Employees Headquarters Website
AstraZeneca PlcView Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Biogen Inc.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Chugai Pharmaceutical Co. Ltd.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
F. Hoffmann La Roche Ltd.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Hansoh Pharmaceutical Group Co. Ltd.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
HBM Holdings Ltd.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Horizon Therapeutics PlcView Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Mitsubishi Chemical Group Corp.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Opexa Therapeutics Inc.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
TG Therapeutics Inc.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Scope

  1. By Application
    1. Introduction / Key Findings
    2. Historical Market Size Value (US$ million) Analysis By Application, 2017 to 2022
    3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Application, 2024 to 2028
      1. Hospitals
      2. Specialty clinics
      3. Homecare
    4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2022
    5. Absolute $ Opportunity Analysis By Application, 2024 to 2028
  2. By Type
    1. Introduction / Key Findings
    2. Historical Market Size Value (US$ million) Analysis By Type, 2017 to 2022
    3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Type, 2024 to 2028
      1. With aquaporin-4 antibodies
      2. Without aquaporin-4 antibodies
    4. Y-o-Y Growth Trend Analysis By Type, 2017 to 2022
    5. Absolute $ Opportunity Analysis By Type, 2024 to 2028
  3. By Region
    1. Introduction / Key Findings
    2. Historical Market Size Value (US$ million) Analysis By Region, 2017 to 2022
    3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Region, 2024 to 2028
      1. North America
      2. Europe
      3. Asia
      4. Rest of World (ROW)
  4. North America Market Analysis 2017 to 2022 and Forecast 2024 to 2028, By Country
    1. Historical Market Size Value (US$ million) Trend Analysis By Market, 2017 to 2022
    2. Market Size Value (US$ million) Forecast By Market, 2024 to 2028
    3. By Country
      1. Canada
      2. US
    4. By Application
    5. By Type
  5. Europe Market Analysis 2017 to 2022 and Forecast 2024 to 2028, By Country
    1. Historical Market Size Value (US$ million) Trend Analysis By Market, 2017 to 2022
    2. Market Size Value (US$ million) Forecast By Market, 2024 to 2028
    3. By Country
      1. UK
    4. By Application
    5. By Type
  6. Asia Market Analysis 2017 to 2022 and Forecast 2024 to 2028, By Country
    1. Historical Market Size Value (US$ million) Trend Analysis By Market, 2017 to 2022
    2. Market Size Value (US$ million) Forecast By Market, 2024 to 2028
    3. By Country
      1. China
      2. India
    4. By Application
    5. By Type
  7. Rest of World (ROW) Market Analysis 2017 to 2022 and Forecast 2024 to 2028, By Country
    1. Historical Market Size Value (US$ million) Trend Analysis By Market, 2017 to 2022
    2. Market Size Value (US$ million) Forecast By Market, 2024 to 2028
    3. By Application
    4. By Type

Major Companies

Market companies

Name Profile Employees Headquarters Website
AstraZeneca PlcView Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Biogen Inc.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Chugai Pharmaceutical Co. Ltd.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
F. Hoffmann La Roche Ltd.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Hansoh Pharmaceutical Group Co. Ltd.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
HBM Holdings Ltd.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Horizon Therapeutics PlcView Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Mitsubishi Chemical Group Corp.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Opexa Therapeutics Inc.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
TG Therapeutics Inc.View Profiletable_profile101-250Santa Clara, California, United States, North Americaavinetworks.com
Click to Unlock the Companies Ranking
technavio-report-thumb
Start your Subscription Today!
Gain Instant Access to 21000+ Market Research Reports!
Start your Subscription